Aldesleukin 22000000 UNT Injection [Proleukin] — RxCUI 105648
RxNorm drug concept · Semantic branded drug
RxCUI 105648
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI105648
Official nameAldesleukin 22000000 UNT Injection [Proleukin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProleukin 1.3 MG Injection; Proleukin 22,000,000 UNT Injection; Proleukin 22000000 UNT Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aldesleukin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Proleukin is the brand name for aldesleukin, a man-made version of a natural immune protein called interleukin-2. It's approved to treat two types of advanced cancer: metastatic ki...
- What exactly is Proleukin, and why has my doctor prescribed it for me?
- You will need to be in the hospital for every dose — there's no at-home version of this treatment. Proleukin is given as a short IV drip (about 15 minutes) every 8 hours in cycles....
- Will I be able to take this at home, or do I have to stay in the hospital?
🕸️ Concept Web — How Aldesleukin 22000000 UNT Injection [Proleukin] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aldesleukin 22000000 UNT Injection [Proleukin]
RxCUI 105648 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Aldesleukin
70223IN
-
Aldesleukin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Proleukin
203760BN
-
Proleukin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aldesleukin Injection
1719781SCDF -
Aldesleukin Injectable Product
1154611SCDG -
Aldesleukin Injection [Proleukin]
1719784SBDF -
Proleukin Injectable Product
1180698SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Aldesleukin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aldesleukin 22000000 UNT Injection
307816SCD -
Aldesleukin 22000000 UNT
1719780SCDC -
Aldesleukin 22000000 UNT [Proleukin]
1719783SBDC
-
Aldesleukin 22000000 UNT Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aldesleukin 22000000 UNT Injection
SCD · 307816 -
Aldesleukin 22000000 UNT
SCDC · 1719780 -
Aldesleukin Injection
SCDF · 1719781 -
Aldesleukin Injectable Product
SCDG · 1154611
Brand-Name Concepts
-
Aldesleukin 22000000 UNT [Proleukin]
SBDC · 1719783 -
Aldesleukin Injection [Proleukin]
SBDF · 1719784 -
Proleukin Injectable Product
SBDG · 1180698 -
Proleukin
BN · 203760
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 105648 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73776-0022-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01) / 1 mL in 1... | PROLEUKIN | Iovance Biotherapeutics, Inc | 2024-07-15 |
Observed labelers:
Iovance Biotherapeutics, Inc (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.